Summary of Purpose
To compare the efficacy of urokinase in combination with heparin with that of heparin alone in reducing the morbidity and mortality in patients with ischemic stroke and lysable lesions.Read More →
The following dates are available for this trial. Trial information last updated on 22 July 2008.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- The Serono company has withdrawn its sponsorship. Alternative sponsorship is being sought.
Randomized, blinded study of approximately 200 patients.
Co-ordination Centre Dept of Neurology Austin & Repatriation Medical Centre, Heidelberg, Victoria 3084 Australiadonnan@austin.unimelb.edu.au